Jan S.
- Country
- Italy
- Department
- Allergology and Immonology Unit
Research Overview
- Non-Inferiority Trial of Depemokimab Versus Mepolizumab or Benralizumab in Severe Eosinophilic Asthma Patients
- Efficacy, Safety, and Tolerability of Remibrutinib in Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines: A Randomized, Double-Blind, Placebo-Controlled Study
- Long-term Efficacy, Safety, and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria: An Extension Study for Phase 3 Completers
Data & Insights
Has run more than one trial at 29 of 193 partner sites.
Specializations
Dermatological Research
The investigator specializes in studying therapeutic approaches for chronic spontaneous urticaria, focusing on innovative treatment solutions for patients with persistent symptoms.
- Urticaria Management
- Long-term Treatment Efficacy
- Therapeutic Tolerance
Their research interests extend to evaluating sustained therapeutic responses in dermatological conditions, particularly examining long-term management strategies.
Clinical Assessment
The investigator focuses on comprehensive evaluation of treatment efficacy and safety profiles in chronic skin conditions, with particular attention to patient response patterns.
- Treatment Response Assessment
- Safety Monitoring
- Clinical Outcomes
Their work involves detailed analysis of therapeutic interventions and their impact on patient well-being over extended periods.
Therapeutic Innovation
The investigator explores advanced therapeutic options for chronic urticaria management, focusing on novel treatment approaches and their long-term benefits.
- Treatment Optimization
- Extended Care Protocols
- Patient Response Patterns
Their research encompasses the evaluation of emerging treatments and their potential to improve patient outcomes in chronic skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.